BUZZ-Humana falls, Clover gains after Medicare quality ratings

Reuters

Oct 11, 2024

** Shares in Humana fall 3.7% while Clover Health Investment gain 4.5% in premarket trade

** CLOV's PPO Medicare Advantage plans earn a 4-star rating for 2025

** Humana is "likely to track in line" with its estimates last week, which pointed to only a quarter of its members remaining enrolled in 2025 for its 4+ rating plans, compared with 94% in 2024, Oppenheimer said in a note

** The U.S. government said on Friday that 62% of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans rated four or more stars down from 74% last year

** About 40% of plans being offered are four stars or higher, down from 42% in 2024, it added

(Reporting by Paolo Laudani)

((Paolo.laudani@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2474003052"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2474003052\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2474003052?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-11 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474003052","market":"us","top_or_hot":-1,"title":"BUZZ-Humana falls, Clover gains after Medicare quality ratings","media":"Reuters","content":"<html><body><p>** Shares in Humana    fall 3.7% while Clover Health Investment    gain 4.5% in premarket trade</p><p>   ** CLOV's PPO Medicare Advantage plans earn a 4-star rating for 2025</p><p>   ** Humana is \"likely to track in line\" with its estimates last week, which pointed to only a quarter of its members remaining enrolled in 2025 for its 4+ rating plans, compared with 94% in 2024, Oppenheimer said in a note</p><p>   ** The U.S. government said on Friday that 62% of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans rated four or more stars down from 74% last year</p><p>   ** About 40% of plans being offered are four stars or higher, down from 42% in 2024, it added</p><p> (Reporting by Paolo Laudani)</p><p>((Paolo.laudani@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Humana falls, Clover gains after Medicare quality ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Humana falls, Clover gains after Medicare quality ratings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-10-11 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>** Shares in Humana    fall 3.7% while Clover Health Investment    gain 4.5% in premarket trade</p><p>   ** CLOV's PPO Medicare Advantage plans earn a 4-star rating for 2025</p><p>   ** Humana is \"likely to track in line\" with its estimates last week, which pointed to only a quarter of its members remaining enrolled in 2025 for its 4+ rating plans, compared with 94% in 2024, Oppenheimer said in a note</p><p>   ** The U.S. government said on Friday that 62% of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans rated four or more stars down from 74% last year</p><p>   ** About 40% of plans being offered are four stars or higher, down from 42% in 2024, it added</p><p> (Reporting by Paolo Laudani)</p><p>((Paolo.laudani@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HUM","symbol_name":"哈门那","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2474003052","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474003052","pubTimestamp":1728636129,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares in Humana    fall 3.7% while Clover Health Investment    gain 4.5% in premarket trade   ** CLOV's PPO Medicare Advantage plans earn a 4-star rating for 2025   ** Humana is \"likely to track in line\" with its estimates last week, which pointed to only a quarter of its members remaining enrolled in 2025 for its 4+ rating plans, compared with 94% in 2024, Oppenheimer said in a note   ** The U.S. government said on Friday that 62% of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans rated four or more stars down from 74% last year   ** About 40% of plans being offered are four stars or higher, down from 42% in 2024, it added ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"HUM":"哈门那","CLOV":"Clover Health Corp"},"translate_title":"医疗保险质量评级后，BUZZ-Humana下跌，Clover上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLOV":0.9,"HUM":0.9},"content_text":"** Shares in Humana    fall 3.7% while Clover Health Investment    gain 4.5% in premarket trade   ** CLOV's PPO Medicare Advantage plans earn a 4-star rating for 2025   ** Humana is \"likely to track in line\" with its estimates last week, which pointed to only a quarter of its members remaining enrolled in 2025 for its 4+ rating plans, compared with 94% in 2024, Oppenheimer said in a note   ** The U.S. government said on Friday that 62% of people currently enrolled in Medicare Advantage plans that cover prescription drugs are covered by plans rated four or more stars down from 74% last year   ** About 40% of plans being offered are four stars or higher, down from 42% in 2024, it added (Reporting by Paolo Laudani)((Paolo.laudani@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}